STAT3-INHIBITOREN

European patent · EP2299999 · In force

Register entry

Publication number
EP2299999
Application number
EP09759351
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 3, 2009
Published
Mar 30, 2011
Granted
Aug 16, 2017
Protection ends at the latest
Jun 2, 2029
Next annual fee due
Jun 30, 2027
IPC classes
A61K 31/275 (2006.01)
A61K 31/19 (2006.01)
C07C 321/00 (2006.01)
A61P 35/00 (2006.01)
Priority
US 58742 P 04.06.2008
PCT application
PCT/US2009/046143 03.06.2009
PCT publication
WO2009/149192 10.12.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Nov 16, 2017

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 16.11.2017

  7. Aug 16, 2017

    Granted

    Published in Swissreg on 16.08.2017

Parties

Holder

Baylor College of Medicine

Baylor College Of Medicine

One Baylor Plaza, Houston, TX 77030-3411, US

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

TWEARDY, David, J.

Houston TX 77005, US

KASEMBELI, Moses, M.

Houston TX 77025, US

XU, Xuejun

Pudong Shanghai 201203, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.